Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo.
Cardiotoxin 1 from cobra (Naja naja atra) venom was tested for its ability to cause necrosis of skeletal muscle cells after i.m. injection into mice. Light and electron microscopic examination of tissue indicated that the toxin caused necrosis of skeletal muscle as early as 30 min after injection. The plasma membranes of affected cells were ruptured in the area of delta lesions, and the myofibrils were condensed into dense clumps alternating with clear areas containing elements of the sarcotubular system and damaged mitochondria. By 24 hr the affected cells appeared as empty 'bags' containing only remnants of myofibrils and swollen mitochondria. To eliminate the possibility that the necrosis was due to contaminating phospholipase A2 (PLA2) activity of the sample, the sample was treated with p-bromophenacyl bromide (p-BPB), a known inhibitor of PLA2 activity. The p-BPB-treated preparation caused myonecrosis in vivo in mice, and the treatment caused a significant decrease in the release of fatty acids and no detectable lysophospholipid in human muscle cell cultures treated in vitro with the preparation, indicating the lack of PLA2 activity. Additionally, purified PLA2 from the same venom failed to cause myonecrosis in vivo at doses equal to or ten times the estimated contaminating concentration. Thus, it is concluded that cardiotoxin 1 from Naja naja atra venom causes necrosis of skeletal muscle cells in vivo upon i.m. injection.
Ownby
C L
CL
Department of Physiological Sciences, Oklahoma State University, Stillwater 74078.
Fletcher
J E
JE
Colberg
T R
TR
D000098:Acetophenones / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D004179:Cobra Cardiotoxin Proteins / Q000737:chemistry / Q000633:toxicity*; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D051379:Mice; D008815:Mice, Inbred Strains; D009132:Muscles / Q000187:drug effects* / Q000473:pathology*; D009336:Necrosis; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D054467:Phospholipases A2; D010738:Type C Phospholipases / Q000378:metabolism
D000098:Acetophenones; D004179:Cobra Cardiotoxin Proteins; D010741:Phospholipases A; D054467:Phospholipases A2; D010738:Type C Phospholipases; C006821:4-bromophenacyl bromide